Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers September 21, 2017
Pharmacy Choice - Pharmaceutical News - Innovus Pharmaceuticals to Release First Quarter 2017 Financial Results and Provide Corporate Update on Friday, May 12, 2017 - September 21, 2017

Pharmacy News Article

 5/15/17 - Innovus Pharmaceuticals to Release First Quarter 2017 Financial Results and Provide Corporate Update on Friday, May 12, 2017

By a News Reporter-Staff News Editor at Pharma Business Week Innovus Pharmaceuticals, Inc., ("Innovus Pharma") (OTCQB: INNV), announced that the Company will release its first quarter 2017 financial results and provide a corporate update on Friday, May 12, 2017, after the close of the U.S. financial markets. The Company will host a conference call at 4:30 p.m. ET/1:30 p.m. PT on the same day to discuss the financial results and recent business developments (see also Innovus Pharmaceuticals, Inc.).

To participate in the call, please dial 1-877-883-0383 for domestic callers or 1-412-902-6506 for international callers. Participant Elite Entry Number: 2679172. A replay of the call will be available for 30 days. To access the replay, dial 1-877-344-7529 domestically or 1-412-317-0088 internationally and reference Conference ID: 10106792. The replay will be available shortly after the end of the conference call. About Innovus Pharmaceuticals, Inc. Headquartered in San Diego, Innovus Pharma is an emerging over-the-counter ("OTC") consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing and development of safe and effective non-prescription medicine and consumer care products to improve men's and women's health and vitality and respiratory diseases. Innovus Pharma delivers innovative and uniquely presented and packaged health solutions through its (a) OTC medicines and consumer and health products, which we market directly; (b) commercial partners to primary care physicians, urologists, gynecologists and therapists; and directly to consumers through our on-line channels, retailers and wholesalers. The Company is dedicated to being a leader in developing and marketing new OTC and branded Abbreviated New Drug Application ("ANDA") products. The Company is actively pursuing opportunities where existing prescription drugs have recently, or are expected to, change from prescription (or Rx) to OTC.

Keywords for this news article include: Innovus Pharmaceuticals Inc., Investment and Finance.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC



(c) 2017 NewsRx LLC

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
Sep 21: Biosimilar Drugs: Legal, Regulatory & Safety Considerations
Last Chance
Sep 22: Influenza 2017-2018: An Update on Prevention and Treatment
Sep 24: Using Effective Communication to Reduce Medication Errors
Sep 25: Management of Major Depressive Disorders
Sep 26: Vitamins, Minerals, and Electrolytes in Older Adults
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415